Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
Title
Grant Type
Focus Area
Country
Application Due Date
COVID-19 Vaccine Patient Education: Addressing Vaccine Hesitancy
Release Date:
Review Process: Pfizer Internal
Education Vaccines All
Quality Improvement Grants to Support the Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Canada
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Research Rare Disease Canada
Junior Investigator Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Junior Investigator Transthyretin Amyloid Polyneuropathy (ATTR-PN) Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
2021 Growth Hormone Research (United States)
Release Date:
Review Process: Expert Review Panel
Research Rare Disease USA
Acromegaly
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Pediatric Endocrinology Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Providing Access to Learning Resources for Tobacco Dependence Treatment
Release Date:
Partner: Duke University
Review Process: Expert Review Panel
Education Internal Medicine Bahrain, Egypt, Kuwait, Oman, Qatar, Saudi Arabia, South Africa, United Arab Emirates
2021 Global ANGPTL3 ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Internal Medicine All
Inflammatory Bowel Disease (Europe, Israel, Turkey, Russia, Canada, Australia, New Zealand and Japan)
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology All
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA